Correlation between the lymphocytic infiltration of tumors and the proliferative activity of cancer cells from surgically treated esophageal carcinoma

Oncology (Switzerland)

Volumn 54, Issue 4, 1997, Pages 311-317

  Ikeguchi, Masahide ^a   Saito, Hiroaki ^a   Katano, Kuniyuki ^a   Tsujitani, Shunichi ^a   Maeta, Michio ^a   Kaibara, Nobuaki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Esophageal squamous cell carcinoma; Ki 67; Tumor lymphocytic infiltration

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CELL PROLIFERATION; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR GROWTH;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; IMMUNITY, CELLULAR; KI-67 ANTIGEN; LYMPHOCYTES; SURVIVAL ANALYSIS;

EID: 0030988705     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227709     Document Type: Article

References (17)

1. Black MM, Freeman C, Mork T: Prognostic significance of microscopic structure of gastric carcinomas and their regional lymph nodes. Cancer 1971;27:703-715.
2. Giorgio AD, Botti C, Tocchi A, Mingazzini P, Flammia M: The influence of tumor lymphocytic infiltration on long term survival of surgically treated colorectal cancer patients. Int Surg 1992:77:256-260.
3. Lam K-Y, Law SY-K, So MK-P, Fok M, Ma LT, Wong J: Prognostic implication of proliferative markers M1B-1 and PCIO in esophageal squamous cell carcinoma. Cancer 1996:77:7-13.
4. Yonemura Y, Ooyama S, Sugikawa K, Nino-miya I, Kamata T, Yamaguchi A, Matsumoto H, Miyazaki I: Growth fractions in gastric carcinomas delected with monoclonal antibody Ki-67. Cancer 1990;65:1130-1134.
5. Kubota Y, Petras RE, Easley KA, Baure TW, Tubbs RR, Fazio VW: Ki-67-dctermined growth fraction versus standard staining and grading parameters in colorectal carcinoma. A multivariate analysis. Cancer 1992:70:2602-2609.
6. Wintzer H-O, Zipfel I, Schultc-Mönling J, Hel-Ierich U, von Kleist S: Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991;67:421-428.
7. Ikeguchi M, Katano K, Oka A, Tsujitani S, Maeta M, Kaibara N: Number of argyrophilic nucleolar organizer regions is a good indicator of lymph node metastasis in patients with esophageal carcinoma. Langenbeck Arch Chir 1995;380:197-202.
8. International Union against Cancer: TNM Classification of Malignant Tumors, ed 2. New York. Springer. 1987. pp 37-42.
9. Japanese Socienty for Esophageal Disease: Guidelines for the clinical and pathological studies on carcinoma of the esophagus. Jpn J Surg 1976;6:69-78.
10. Hong MK, Laskin WB, Herman BE, Johnston MH, Vargo JJ, Steinberg SM, Allegra CJ, Johnston PG: Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett’s esophagus. Cancer 1995:75: 423-429.
11. Lu JP, Xian MS, Hayashi K: Morphologic features in esophageal squamous cell carcinoma of young adults in north China. Cancer 1994:74: 573-577.
12. Morita M, Kuwano H, Matsuda H, Moriguchi S, Sugimachi K: Prognostic significance of argyrophilic nucleolar organizer regions in esophageal carcinoma. Cancer Res 1991;51:5339-5341.
13. Yoshida Y, Okamura T, Ezaki T, Shirakusa T: Predictors of postoperative distant recurrences in esophageal carcinoma. Ann Thorac Surg 1994:57:886-889.
14. Gerdes J, Lempke H, Baisch H, Wacker H-H. Schwab U, Stein H: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by a monoclonal antibody Ki-67. J Immunol 1984:133:1710-1715.
15. Gerdes J, Li L, Schlueter C, Duchrow M, Woh-lenberg C, Gerlach C, Stahmer I, Kloth S, Brandt E, Flad H-D: Immunobiochemical and molecular biologic characterization of cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-873.
16. Balch CM, Riley LB, Bae YJ, Salmeron MA, Platsoucas CD, von Eschenbach A, Itoh K: Patterns of human tumor-infiltrating lymphocytes in 120 human cancers. Arch Surg 1990:125: 200-205.
17. Balch CM: Immune responses to tumor antigens and their clinical applications. Surgerv 1986:100:562-571.